Related Experiment Videos

Graves' disease in 2.5 years old girl - 6-years-long observation

Olimpia Jonak1, Joanna Połubok1, Ewa Barg2

  • 1Student's Association of Science, Wroclaw Medical University.

Insights

Pediatric Graves' disease, a rare autoimmune condition, can be effectively treated in young children with antithyroid drugs, leading to long-term remission. Early diagnosis and management are crucial for favorable outcomes in pediatric hyperthyroidism.

Area of Science:

  • Pediatric Endocrinology
  • Autoimmune Diseases
  • Thyroid Disorders

Background:

  • Pediatric Graves' disease is uncommon in young children.
  • It is more prevalent in those with a family history of autoimmune thyroid disease or existing autoimmune conditions.
  • This case highlights a rare occurrence in a prepubertal child.

Purpose of the Study:

  • To report a case of pediatric Graves' disease in a young child.
  • To discuss the diagnosis and management of hyperthyroidism in a prepubertal patient.
  • To emphasize the possibility of long-term remission with antithyroid drug therapy.

Main Methods:

  • A 2.5-year-old girl presented with tachycardia and subfebrile temperature.
  • Laboratory tests confirmed hyperthyroidism (low TSH, high FT3/FT4) with negative thyroid antibodies.
  • Treatment involved methimazole and propranolol, followed by monitoring of thyroid function.

Main Results:

  • The patient was diagnosed with Graves' disease and treated with methimazole and propranolol.
  • Thyroid function normalized within one year of treatment.
  • The child achieved long-term remission and is off medication at age 8, despite persistent atopy.

Conclusions:

  • Tachycardia in children warrants consideration for hyperthyroidism.
  • Antithyroid drug therapy can achieve long remission in young children with Graves' disease.
  • Treatment should be tailored to the individual patient's age and condition.
Abstract

Related Concept Videos